BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. 詳細を表示
FLORHAM PARK, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...
FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company developing innovative...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1257 | -7.15953750641 | 1.7557 | 1.7557 | 1.5601 | 21285 | 1.61875376 | CS |
4 | -0.1391 | -7.8627550732 | 1.7691 | 1.8556 | 1.43 | 34005 | 1.62266675 | CS |
12 | -0.8 | -32.9218106996 | 2.43 | 2.53 | 1.43 | 24878 | 1.79930465 | CS |
26 | -0.71 | -30.3418803419 | 2.34 | 2.6 | 1.43 | 25275 | 1.99315352 | CS |
52 | 0.73 | 81.1111111111 | 0.9 | 4 | 0.7777 | 81921 | 2.56073455 | CS |
156 | -2.98 | -64.6420824295 | 4.61 | 5.175 | 0.542 | 228472 | 2.1532443 | CS |
260 | -13.79 | -89.4293125811 | 15.42 | 33 | 0.542 | 456138 | 13.14811705 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約